Equities

ALT

AU000000ALT0

Medical Equipment, Supplies & Distribution

Market Closed - Australian S.E. Other stock markets 11:32:57 2023-02-27 pm EST			5-day change	1st Jan Change
0.001 ^AUD	-.--%		-.--%	-.--%

2023	Analytica Appoints Voluntary Administrators	MT
2023	Analytica CEO Resigns	MT

Analytica Limited Reports Earnings Results for the Second Quarter Ended December 31, 2020

February 26, 2021 at 01:18 am EST

Analytica Limited announced earnings results for the second quarter ended December 31, 2020. For the second quarter, the company announced basic loss per share from continuing operations was AUD 0.00013 compared to AUD 0.00012 a year ago. For the half year, sales was AUD 0 compared to AUD 10,889 a year ago. Net loss was AUD 449,565 compared to AUD 406,243 a year ago.

Latest news about ANALYTICA

Analytica Appoints Voluntary Administrators	23-06-12	MT
Analytica CEO Resigns	23-05-12	MT
Dr Michael Monsour Will Take on the Role of Executive Chairman of Analytica Limited	23-05-11	CI
Analytica Limited Announces Resignation of Geoff Daly as CEO	23-05-11	CI
Analytica Limited Reports Earnings Results for the Half Year Ended December 31, 2022	23-02-27	CI
Analytica Limited Reports Earnings Results for the Full Year Ended June 30, 2022	22-08-31	CI
Analytica Limited Auditor Raises 'Going Concern' Doubt	22-08-30	CI
Analytica Secures Canadian Patent for Pelvic Floor Exercise System	22-07-13	MT
Analytica Secures European, Indian Patent for Training Device	22-05-18	MT
Analytica Limited Reports Earnings Results for the Half Year Ended December 31, 2021	22-02-22	CI
Analytica Secures US Patent for PeriCoach Device	21-11-10	MT
Analytica Limited Auditor Raises 'Going Concern' Doubt	21-09-29	CI
Analytica Limited Reports Earnings Results for the Full Year Ended June 30, 2021	21-08-31	CI
Analytica : Secures US Patent for Pelvic Floor Exercise System	21-04-30	MT
Analytica Announces Expansion of Enhanced Infusion System into Middle East	21-04-27	CI
Analytica : Plans Up to $3 Million Share Placement	21-04-23	MT
Analytica : Enters Deal to Distribute Intravenous Flow Monitoring Device in Middle East	21-04-20	MT
Analytica Limited Enters into Joint Venture Agreement to Manufacture, Distribute and Market the System in China, Macau, Hong Kong and Taiwan	21-03-31	CI
Analytica Limited Reports Earnings Results for the Second Quarter Ended December 31, 2020	21-02-26	CI
Analytica Ltd Announces Publication of an Independent Clinical Trial from the University of New Mexico in the Journal of Female Pelvic Medicine & Reconstructive Surgery, the Official Journal of the American Urogynecologic Society, Demonstrating PeriCoach Non-Inferiority to In- Clinic Pelvic Floor Physical Therapy	20-11-19	CI
Analytica Limited Reports Earnings Results for the Full Year Ended June 30, 2020	20-08-30	CI
Analytica Ltd Announces Resignation of Thomas Lönngren, Non-Executive Director	20-08-17	CI
Analytica Limited Reports Earnings Results for the Half Year Ended December 31, 2019	20-02-26	CI
Analytica Ltd Announces Middle East Distribution Agreement Supplementary Disclosure	19-12-12	CI
Analytica Ltd. Reports Earnings Results for the Full Year Ended June 30, 2019	19-08-22	CI

Chart ANALYTICA

Duration

Period

More charts

Company Profile

Analytica Limited is an Australia-based product development and commercialization company that is focused on Class I and II medical device products. Its lead product is the PeriCoach System- an e-health treatment system for women who suffer stress urinary incontinence. PeriCoach includes a device, Web portal and smartphone app and the device evaluates activity in pelvic floor muscles. This information is transmitted to a smartphone app and can be loaded to a cloud database where physicians can monitor patient progress via Web portal. The Company is also the developer of the Enhanced Infusion System (EIS), a combination of technologies developed under the project names AutoStart and AutoFlush. It is also commercializing the AutoStart Burette infusion system. The EIS is a simple and inexpensive IV add-in technology to reduce nursing monitoring costs, reduce embolism risk, improve infection control and automatically restart flow after medication delivery during intravenous fluid infusion.

Sector

Medical Equipment, Supplies & Distribution

More about the company

Income Statement Evolution

More financial data

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
ANALYTICA	-.--%	3.08M
ABBOTT LABORATORIES	-4.72%	182B
MEDTRONIC PLC	+3.96%	114B
BECTON, DICKINSON AND COMPANY	-2.93%	68.38B
DEXCOM, INC.	+6.30%	52.46B
CENCORA, INC.	+8.02%	44.25B
HOYA CORPORATION	+7.52%	43.55B
METTLER-TOLEDO INTERNATIONAL, INC.	+26.18%	32.69B
TERUMO CORPORATION	+17.85%	26.73B
WEST PHARMACEUTICAL SERVICES, INC.	+0.57%	25.79B

Other Medical Equipment, Supplies & Distribution